CDMO Competitive Assessment in the USA and Europe

Objective :

Competitors assessment of companies active in the pharma CDMO area

Problem Statement:

A CDMO client based in Europe, involved DelveInsight to provide in-depth competitor assessment of companies active in the pharma CDMO area, in order to understand effective landscaping and conduct strategic decision-making for gaining competitive advantage. The client wanted to expand their geographical scope and improve their product portfolio, for which they also requested competitive benchmarking outcomes from DelveInsight.

Our Methodology:

• Extensive secondary research
• List of CDMOs active in the European region
• Provided a robust competitive landscape
• Detailed profiling of the companies
• Service offerings
• Therapeutic area involvement
• Manufacturing capabilities and
• Details of market outreach

Results:

• A growing number of companies in drug development has led to a large surge of CDMO companies in the European and the USA region
• A growing number of companies in drug development has led to a large surge of CDMO companies in the European and the USA region
• Companies are developing antibodies and cell therapy candidates due to the vast research required .
• Protein manufacturing captures a large segment where companies are involved in contract development and manufacturing
• European Market outshines the no. of CMOs and CDMOs as well as the level of manufacturing output
• Competitive intelligence assessment pointed the top players in the market and their differentiating USPs